Mirapex 0.125 mg (Pramipexole Dihydrochloride Monohydrate TABLET) 0.125 MG

Mirapex 0.125 mg tablets contain pramipexole, a medication used to manage symptoms of Parkinson's disease and restless legs syndrome. This oral tablet is designed to support movement control and comfort.

Strength

0.125 MG

Pack Size

Manufacturer / TM Owner

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mirapex 0.125 mg tablets are commonly used to alleviate symptoms associated with Parkinson's disease, such as stiffness, tremors, and muscle spasms. Additionally, they may be prescribed to treat restless legs syndrome, helping to reduce the urge to move the legs. Pramipexole works by affecting dopamine levels in the brain, which can improve motor function and reduce discomfort. Always consult a healthcare provider to determine if this medication is suitable for your condition.

Side Effects

Common effects of Mirapex 0.125 mg tablets may include dizziness, nausea, and fatigue. Some users report drowsiness or lightheadedness, particularly when starting treatment or adjusting dosages. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare professional.

Precautions & Warnings

Mirapex 0.125 mg tablets should be handled with care, stored at room temperature, and kept out of reach of children. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. Avoid sudden changes in dosage without medical advice, as this can affect the medication's efficacy and safety.

Avoid Interactions

Mirapex 0.125 mg tablets may interact with certain medications, including those that affect dopamine levels or cause drowsiness. Alcohol and other central nervous system depressants should be avoided, as they can enhance the sedative effects of pramipexole. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Mirapex 0.125 mg tablets are used to manage symptoms of Parkinson's disease and restless legs syndrome, helping to improve movement and reduce discomfort.

Mirapex 0.125 mg tablets are taken orally, typically with or without food, as directed by a healthcare provider.

Common side effects may include dizziness, nausea, fatigue, and drowsiness. These effects are usually mild and temporary.

Mirapex 0.125 mg may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

Alcohol should be avoided while taking Mirapex 0.125 mg, as it can enhance the sedative effects of the medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.